Cargando…

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures

The present study was aimed to investigate the application of right thansthoracic Ivor–Lewis (IL), left transthoracic (LTT), and left thoracoabdominal (LTA) approach in Siewert type II adenocarcinoma of esophagogastric junction (AEG). The data of 196 patients with Siewert type II AEG received surgic...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiao-Feng, Yue, Jie, Tang, Peng, Shang, Xiao-Bin, Jiang, Hong-Jing, Yu, Zhen-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319526/
https://www.ncbi.nlm.nih.gov/pubmed/28207537
http://dx.doi.org/10.1097/MD.0000000000006120
_version_ 1782509397578088448
author Duan, Xiao-Feng
Yue, Jie
Tang, Peng
Shang, Xiao-Bin
Jiang, Hong-Jing
Yu, Zhen-Tao
author_facet Duan, Xiao-Feng
Yue, Jie
Tang, Peng
Shang, Xiao-Bin
Jiang, Hong-Jing
Yu, Zhen-Tao
author_sort Duan, Xiao-Feng
collection PubMed
description The present study was aimed to investigate the application of right thansthoracic Ivor–Lewis (IL), left transthoracic (LTT), and left thoracoabdominal (LTA) approach in Siewert type II adenocarcinoma of esophagogastric junction (AEG). The data of 196 patients with Siewert type II AEG received surgical resection in our cancer center between January 2014 and April 2016 was retrospectively analyzed. Finally, 136 patients met the inclusion criteria were enrolled in the study and divided into the IL (47 cases), LTT (51 cases), and LTA group (38 cases). Clinical and short-term treatment effects were compared among the 3 groups. The patients with weight loss, diabetes, and heart disease increased in the LTT group (P = 0.054, P = 0.075, and P = 0.063, respectively). Operation time was significantly longest in the IL group (P < 0.001), but the amount of bleeding and tumor size did not significantly differ among the 3 groups (P = 0.176 and P = 0.228, respectively). The IL group had the significantly longest proximal surgical margin (P < 0.001) and most number of total (P < 0.001) and thoracic lymph nodes (P < 0.001) dissected. Both the IL and LTA groups had more abdominal lymph nodes dissected than the LTT group (P < 0.001). In general, the IL and LTT groups had the highest dissection rates of every station of thoracic (P < 0.05) and lower mediastinal lymph nodes (P < 0.05), respectively. The dissection rate of the paracardial, left gastric artery, and gastric lesser curvature lymph nodes did not differ significantly among the 3 groups (P > 0.05), but the dissection rate of the hepatic artery, splenic artery, and celiac trunk lymph nodes was significantly highest in the IL group (P < 0.05). Postoperative hospital stay, perioperative complications, and mortality did not differ significantly among the 3 groups (P > 0.05). Compared with the traditional left transthoracic approach, the Ivor–Lewis approach did not increase the perioperative mortality and complication rates in Siewert type II AEG, but obtained satisfactory length of the proximal surgical margin, and was better than the left transthoracic approach in thoracic and abdominal lymph node dissection. However, the advantages of Ivor–Lewis procedure requires further follow-up and validation through prospective randomized controlled trials.
format Online
Article
Text
id pubmed-5319526
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53195262017-03-02 Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures Duan, Xiao-Feng Yue, Jie Tang, Peng Shang, Xiao-Bin Jiang, Hong-Jing Yu, Zhen-Tao Medicine (Baltimore) 7100 The present study was aimed to investigate the application of right thansthoracic Ivor–Lewis (IL), left transthoracic (LTT), and left thoracoabdominal (LTA) approach in Siewert type II adenocarcinoma of esophagogastric junction (AEG). The data of 196 patients with Siewert type II AEG received surgical resection in our cancer center between January 2014 and April 2016 was retrospectively analyzed. Finally, 136 patients met the inclusion criteria were enrolled in the study and divided into the IL (47 cases), LTT (51 cases), and LTA group (38 cases). Clinical and short-term treatment effects were compared among the 3 groups. The patients with weight loss, diabetes, and heart disease increased in the LTT group (P = 0.054, P = 0.075, and P = 0.063, respectively). Operation time was significantly longest in the IL group (P < 0.001), but the amount of bleeding and tumor size did not significantly differ among the 3 groups (P = 0.176 and P = 0.228, respectively). The IL group had the significantly longest proximal surgical margin (P < 0.001) and most number of total (P < 0.001) and thoracic lymph nodes (P < 0.001) dissected. Both the IL and LTA groups had more abdominal lymph nodes dissected than the LTT group (P < 0.001). In general, the IL and LTT groups had the highest dissection rates of every station of thoracic (P < 0.05) and lower mediastinal lymph nodes (P < 0.05), respectively. The dissection rate of the paracardial, left gastric artery, and gastric lesser curvature lymph nodes did not differ significantly among the 3 groups (P > 0.05), but the dissection rate of the hepatic artery, splenic artery, and celiac trunk lymph nodes was significantly highest in the IL group (P < 0.05). Postoperative hospital stay, perioperative complications, and mortality did not differ significantly among the 3 groups (P > 0.05). Compared with the traditional left transthoracic approach, the Ivor–Lewis approach did not increase the perioperative mortality and complication rates in Siewert type II AEG, but obtained satisfactory length of the proximal surgical margin, and was better than the left transthoracic approach in thoracic and abdominal lymph node dissection. However, the advantages of Ivor–Lewis procedure requires further follow-up and validation through prospective randomized controlled trials. Wolters Kluwer Health 2017-02-17 /pmc/articles/PMC5319526/ /pubmed/28207537 http://dx.doi.org/10.1097/MD.0000000000006120 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 7100
Duan, Xiao-Feng
Yue, Jie
Tang, Peng
Shang, Xiao-Bin
Jiang, Hong-Jing
Yu, Zhen-Tao
Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title_full Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title_fullStr Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title_full_unstemmed Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title_short Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
title_sort lymph node dissection for siewert ii esophagogastric junction adenocarcinoma: a retrospective study of 3 surgical procedures
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319526/
https://www.ncbi.nlm.nih.gov/pubmed/28207537
http://dx.doi.org/10.1097/MD.0000000000006120
work_keys_str_mv AT duanxiaofeng lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures
AT yuejie lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures
AT tangpeng lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures
AT shangxiaobin lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures
AT jianghongjing lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures
AT yuzhentao lymphnodedissectionforsiewertiiesophagogastricjunctionadenocarcinomaaretrospectivestudyof3surgicalprocedures